Sandoz Adds To Anti-Infectives With Astellas Mycamine Deal

Global Micafungin Rights Valued At Up To $75m Upfront Plus Milestone Payments

Jan 24 2023

• By David Wallace

Sandoz and Astellas have struck a deal for Mycamine • Source: Shutterstock

More from Deals

More from Business